User login
The University of Arizona (UA) Cancer Center has a new interim director, two hematologists have earned new positions at City of Hope, and an assistant professor has joined Fox Chase Cancer Center.
William Cance, MD, has been appointed interim director of the UA Cancer Center. In this role, he will oversee clinical operations and research at the center’s primary locations in Tucson and Phoenix. He will also lead the UA Cancer Center’s efforts to renew its 5-year Cancer Center Support Grant from the National Cancer Institute (NCI).
In addition to his new role, Dr. Cance is a professor at the UA Colleges of Medicine and Pharmacy in Phoenix. He is board certified in general surgery and specializes in thyroid cancer, parathyroid disease, sarcoma, and gastrointestinal cancer. Dr. Cance has received funding from NCI, has served on the NCI Board of Scientific Counselors, and is a member of NCI Subcommittee F.
In other news, Larry Kwak, MD, PhD, has been appointed the deputy director of the Hematologic Malignancies and Stem Cell Transplantation Institute at City of Hope in Duarte, Calif. Dr. Kwak will work with the director of the Institute, Stephen J. Forman, MD, to oversee recruitment, clinical and laboratory research, and faculty development.
Dr. Kwak is also director of the Toni Stephenson Lymphoma Center, vice president and deputy director of the comprehensive cancer center, and the Dr. Michael Friedman Professor in Translational Medicine. Dr. Kwak was named one of TIME magazine’s “100 Most Influential People,” received the Chang-Yul Oh Memorial Award from the Korean Medical Association, and won the Ho-Am Prize in Medicine.
Also at City of Hope, Tanya Siddiqi, MD, has been appointed director of the chronic lymphocytic leukemia (CLL) program within the Toni Stephenson Lymphoma Center of the Hematologic Malignancies and Stem Cell Transplantation Institute. In this role, Dr. Siddiqi will oversee research efforts related to CLL. This includes maintaining the CLL tissue bank she developed, conducting translational studies and clinical trials, and investigating novel therapies for CLL.
Dr. Siddiqi is also an associate clinical professor in the department of hematology & hematopoietic cell transplantation, is the supervising physician of City of Hope’s anticoagulation clinic, and works in the Gehr Family Center for Leukemia Research. Dr. Siddiqi is a member of the National Comprehensive Cancer Network panels for CLL/SLL/hairy cell leukemia and venous thromboembolism.
Lastly, James M. Martin, MD, has been appointed assistant professor in the hematology and bone marrow transplant program within the department of hematology/oncology at Fox Chase Cancer Center in Philadelphia.
Dr. Martin received a medical degree from Ohio State University, Columbus, and completed an internship and residency at Rhode Island Hospital/Brown University, in Providence. He joined Fox Chase Cancer Center/Temple University in 2016 for a 3-year fellowship.
Movers in Medicine highlights career moves and personal achievements by hematologists and oncologists. Did you switch jobs, take on a new role, climb a mountain? Tell us all about it at hematologynews@mdedge.com, and you could be featured in Movers in Medicine.
The University of Arizona (UA) Cancer Center has a new interim director, two hematologists have earned new positions at City of Hope, and an assistant professor has joined Fox Chase Cancer Center.
William Cance, MD, has been appointed interim director of the UA Cancer Center. In this role, he will oversee clinical operations and research at the center’s primary locations in Tucson and Phoenix. He will also lead the UA Cancer Center’s efforts to renew its 5-year Cancer Center Support Grant from the National Cancer Institute (NCI).
In addition to his new role, Dr. Cance is a professor at the UA Colleges of Medicine and Pharmacy in Phoenix. He is board certified in general surgery and specializes in thyroid cancer, parathyroid disease, sarcoma, and gastrointestinal cancer. Dr. Cance has received funding from NCI, has served on the NCI Board of Scientific Counselors, and is a member of NCI Subcommittee F.
In other news, Larry Kwak, MD, PhD, has been appointed the deputy director of the Hematologic Malignancies and Stem Cell Transplantation Institute at City of Hope in Duarte, Calif. Dr. Kwak will work with the director of the Institute, Stephen J. Forman, MD, to oversee recruitment, clinical and laboratory research, and faculty development.
Dr. Kwak is also director of the Toni Stephenson Lymphoma Center, vice president and deputy director of the comprehensive cancer center, and the Dr. Michael Friedman Professor in Translational Medicine. Dr. Kwak was named one of TIME magazine’s “100 Most Influential People,” received the Chang-Yul Oh Memorial Award from the Korean Medical Association, and won the Ho-Am Prize in Medicine.
Also at City of Hope, Tanya Siddiqi, MD, has been appointed director of the chronic lymphocytic leukemia (CLL) program within the Toni Stephenson Lymphoma Center of the Hematologic Malignancies and Stem Cell Transplantation Institute. In this role, Dr. Siddiqi will oversee research efforts related to CLL. This includes maintaining the CLL tissue bank she developed, conducting translational studies and clinical trials, and investigating novel therapies for CLL.
Dr. Siddiqi is also an associate clinical professor in the department of hematology & hematopoietic cell transplantation, is the supervising physician of City of Hope’s anticoagulation clinic, and works in the Gehr Family Center for Leukemia Research. Dr. Siddiqi is a member of the National Comprehensive Cancer Network panels for CLL/SLL/hairy cell leukemia and venous thromboembolism.
Lastly, James M. Martin, MD, has been appointed assistant professor in the hematology and bone marrow transplant program within the department of hematology/oncology at Fox Chase Cancer Center in Philadelphia.
Dr. Martin received a medical degree from Ohio State University, Columbus, and completed an internship and residency at Rhode Island Hospital/Brown University, in Providence. He joined Fox Chase Cancer Center/Temple University in 2016 for a 3-year fellowship.
Movers in Medicine highlights career moves and personal achievements by hematologists and oncologists. Did you switch jobs, take on a new role, climb a mountain? Tell us all about it at hematologynews@mdedge.com, and you could be featured in Movers in Medicine.
The University of Arizona (UA) Cancer Center has a new interim director, two hematologists have earned new positions at City of Hope, and an assistant professor has joined Fox Chase Cancer Center.
William Cance, MD, has been appointed interim director of the UA Cancer Center. In this role, he will oversee clinical operations and research at the center’s primary locations in Tucson and Phoenix. He will also lead the UA Cancer Center’s efforts to renew its 5-year Cancer Center Support Grant from the National Cancer Institute (NCI).
In addition to his new role, Dr. Cance is a professor at the UA Colleges of Medicine and Pharmacy in Phoenix. He is board certified in general surgery and specializes in thyroid cancer, parathyroid disease, sarcoma, and gastrointestinal cancer. Dr. Cance has received funding from NCI, has served on the NCI Board of Scientific Counselors, and is a member of NCI Subcommittee F.
In other news, Larry Kwak, MD, PhD, has been appointed the deputy director of the Hematologic Malignancies and Stem Cell Transplantation Institute at City of Hope in Duarte, Calif. Dr. Kwak will work with the director of the Institute, Stephen J. Forman, MD, to oversee recruitment, clinical and laboratory research, and faculty development.
Dr. Kwak is also director of the Toni Stephenson Lymphoma Center, vice president and deputy director of the comprehensive cancer center, and the Dr. Michael Friedman Professor in Translational Medicine. Dr. Kwak was named one of TIME magazine’s “100 Most Influential People,” received the Chang-Yul Oh Memorial Award from the Korean Medical Association, and won the Ho-Am Prize in Medicine.
Also at City of Hope, Tanya Siddiqi, MD, has been appointed director of the chronic lymphocytic leukemia (CLL) program within the Toni Stephenson Lymphoma Center of the Hematologic Malignancies and Stem Cell Transplantation Institute. In this role, Dr. Siddiqi will oversee research efforts related to CLL. This includes maintaining the CLL tissue bank she developed, conducting translational studies and clinical trials, and investigating novel therapies for CLL.
Dr. Siddiqi is also an associate clinical professor in the department of hematology & hematopoietic cell transplantation, is the supervising physician of City of Hope’s anticoagulation clinic, and works in the Gehr Family Center for Leukemia Research. Dr. Siddiqi is a member of the National Comprehensive Cancer Network panels for CLL/SLL/hairy cell leukemia and venous thromboembolism.
Lastly, James M. Martin, MD, has been appointed assistant professor in the hematology and bone marrow transplant program within the department of hematology/oncology at Fox Chase Cancer Center in Philadelphia.
Dr. Martin received a medical degree from Ohio State University, Columbus, and completed an internship and residency at Rhode Island Hospital/Brown University, in Providence. He joined Fox Chase Cancer Center/Temple University in 2016 for a 3-year fellowship.
Movers in Medicine highlights career moves and personal achievements by hematologists and oncologists. Did you switch jobs, take on a new role, climb a mountain? Tell us all about it at hematologynews@mdedge.com, and you could be featured in Movers in Medicine.